Aurinia Pharmaceuticals saw the highest growth of 1.99% in patent filings and 0.49% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 1.99% and grants by 0.49%. GlobalData’s DataBook provides a comprehensive analysis of Aurinia Pharmaceuticals‘s patent filings and grants. Buy the databook here.

Smarter leaders trust GlobalData

Aurinia Pharmaceuticals has been focused on protecting inventions in Australia(AU) with two publications in Q2 2024

The Australia(AU) Patent Office dominates the patent filings with nearly 50% of filings. The Australia(AU), Hungary(HU), Israel(IL), and European Patent Office(EPO) patent Office are among the top ten patent offices where Aurinia Pharmaceuticals is filings its patents. Among the top granted patent authorities, Aurinia Pharmaceuticals has 50% of its grants in Spain(ES).

AbbVie and Hepion Pharmaceuticals could be the strongest competitors for Aurinia Pharmaceuticals

In terms of grant share, Aurinia Pharmaceuticals stands in sixth position among its competitors. AbbVie and Hepion Pharmaceuticals secured the top positions according to recent patent publication data.

Patents related to rare diseases lead Aurinia Pharmaceuticals's portfolio

Aurinia Pharmaceuticals has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and 100% of patents were granted in Q2 2024.

Kidney disease (nephropathy) related patents lead Aurinia Pharmaceuticals portfolio followed by lupus nephritis, and cyst

Aurinia Pharmaceuticals has highest number of patents in kidney disease (nephropathy) followed by lupus nephritis, cyst. For kidney disease (nephropathy), nearly 43% of patents were filed and 50% of patents were granted in Q2 2024.

For comprehensive analysis of Aurinia Pharmaceuticals's filings and grants, buy the databook here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.

Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.